Natural Product: NPC578663

Natural Product IDNPC578663
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(2~{R},3~{R},4~{R},5~{S})-2-(6-aminopurin-9-yl)-5-[[[(2~{R},3~{S},4~{S},5~{S})-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyldisulfanyl]methyl]tetrahydrofuran-3,4-diol
IUPAC Name (2~{R},3~{R},4~{R},5~{S})-2-(6-aminopurin-9-yl)-5-[[[(2~{R},3~{S},4~{S},5~{S})-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyldisulfanyl]methyl]tetrahydrofuran-3,4-diol
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey HYGRWPFOTXXMNB-NJNOBOSFSA-N
Standard InCHI InChI=1S/C20H24N10O6S2/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(35-19)1-37-38-2-8-12(32)14(34)20(36-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H2,21,23,25)(H2,22,24,26)/t7-,8+,11+,12-,13-,14+,19-,20+
SMILES NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CSSC[C@@H]2O[C@H](N3C=NC4=C(N)N=CN=C43)[C@@H](O)[C@@H]2O)[C@H](O)[C@H]1O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   564.13 Volume:   481.773
?
Van der Waals volume.
Dense:   1.171 LogP:   -1.282
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   -0.627
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.49
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   7.0 Rigid Bonds:   30.0
TPSA:   238.62
?
Topological Polar Surface Area.
H-Bond Acceptor:   16.0
H-Bond Donor:   8.0 Rings:   6.0
Heavy Atoms:   18.0

MedChem Properties

QED Drug-Likeness Score:   0.11 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.773 Fsp3:   0.5
MCE-18:   120.133
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.189 Fluc inhibitor:   0.005
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.081
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.199
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.679 Promiscuous compounds:   0.494

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.837 MDCK Permeability:   -5.221
Pgp-inhibitor:   0.0 Pgp-substrate:   0.101
PAMPA:   0.999
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.994
20% Bioavailability (F20%):   0.037 30% Bioavailability (F30%):   0.999
50% Bioavailability (F50%):   0.9

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.756 MRP1:   0.01
Plasma Protein Binding (PPB):   40.323% Volume Distribution (VD):   -0.057
Fu: 53.354%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.0
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.099
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.002
HLM stability:   0.001
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.751 Half-life (T1/2):  1.938

ADMET: Toxicity

hERG Blockers:  0.073 hERG Blockers (10um):  0.17
Human Hepatotoxicity (H-HT):  0.812 Drug-induced Liver Injury (DILI):  1.0
AMES Toxicity:  0.984 Rat Oral Acute Toxicity:  0.489
Maximum Recommended Daily Dose:  0.705 Skin Sensitization:  0.997
Carcinogencity:  0.393 Eye Corrosion:  0.0
Eye Irritation:  0.011 Respiratory Toxicity:  0.464
Drug-induced Neurotoxicity:  0.964 Ototoxicity:  0.941
Hematotoxicity:  0.971 Drug-induced Nephrotoxicity:  0.986
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.263
A549 Cytotoxicity:  0.891 Hek293 Cytotoxicity:  0.72
BCF:   0.223
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.809
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.625
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.651
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14594 Trachycladus laevispirulifer Species Trachycladidae Eukaryota n.a. n.a. n.a. PMID[11374963]
NPO14594 Trachycladus laevispirulifer Species Trachycladidae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC578663 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.807 Intermediate Similarity NPC136349
0.807 Intermediate Similarity NPC219313
0.75 Intermediate Similarity NPC156461
0.75 Intermediate Similarity NPC107374
0.75 Intermediate Similarity NPC600382
0.75 Intermediate Similarity NPC612067
0.7455 Intermediate Similarity NPC317821
0.7419 Intermediate Similarity NPC185991
0.7419 Intermediate Similarity NPC321814
0.7302 Intermediate Similarity NPC328479
0.7015 Intermediate Similarity NPC324484
0.697 Remote Similarity NPC324198
0.697 Remote Similarity NPC326529
0.697 Remote Similarity NPC319100
0.6866 Remote Similarity NPC130586
0.6667 Remote Similarity NPC174802
0.6571 Remote Similarity NPC606410
0.6479 Remote Similarity NPC316618
0.6479 Remote Similarity NPC323091
0.6301 Remote Similarity NPC484199
0.623 Remote Similarity NPC229974
0.6216 Remote Similarity NPC484196
0.589 Remote Similarity NPC606116
0.5775 Remote Similarity NPC195140
0.5714 Remote Similarity NPC209525
0.5714 Remote Similarity NPC161659
0.5676 Remote Similarity NPC325906
0.5625 Remote Similarity NPC609472
0.5588 Remote Similarity NPC85689
0.5556 Remote Similarity NPC33996
0.5538 Remote Similarity NPC309832
0.5493 Remote Similarity NPC164952
0.5417 Remote Similarity NPC302778
0.5417 Remote Similarity NPC329404
0.5417 Remote Similarity NPC212551
0.5352 Remote Similarity NPC121222
0.5278 Remote Similarity NPC472816
0.5278 Remote Similarity NPC600171
0.5231 Remote Similarity NPC609036
0.5217 Remote Similarity NPC605318
0.5211 Remote Similarity NPC239737
0.5169 Remote Similarity NPC21461
0.5152 Remote Similarity NPC164665
0.5143 Remote Similarity NPC211025
0.5075 Remote Similarity NPC269827
0.5075 Remote Similarity NPC189068
0.5065 Remote Similarity NPC481375

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC578663 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.807 Intermediate Similarity NPD548 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD249 Phase 4
0.75 Intermediate Similarity NPD250 Phase 4
0.7419 Intermediate Similarity NPD283 Phase 4
0.7188 Intermediate Similarity NPD4171 Clinical (unspecified phase)
0.697 Remote Similarity NPD338 Approved
0.6667 Remote Similarity NPD339 Phase 2
0.5676 Remote Similarity NPD1777 Phase 4
0.5526 Remote Similarity NPD1776 Approved
0.5303 Remote Similarity NPD193 Phase 2
0.5278 Remote Similarity NPD1369 Phase 2
0.5278 Remote Similarity NPD242 Phase 4
0.5256 Remote Similarity NPD1732 Phase 3
0.5152 Remote Similarity NPD186 Phase 1
0.5075 Remote Similarity NPD195 Approved
0.5068 Remote Similarity NPD1750 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data